Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study

JP Fournier, A Sommet, R Bourrel, S Oustric… - European journal of …, 2012 - Springer
Purpose Non-steroidal anti-inflammatory drugs (NSAIDs) are known to antagonize the effects
of antihypertensive drugs, and these associations can lead to an increase in arterial blood …

Analgesic drug consumption increases after knee arthroplasty: a pharmacoepidemiological study investigating postoperative pain

R Fuzier, I Serres, R Bourrel, A Palmaro, JL Montastruc… - PAIN®, 2014 - Elsevier
Knee arthroplasty remains the gold standard in the treatment of severe osteoarthritis. Chronic
postoperative pain has been reported with a prevalence ranging from 15% to 47%. The …

Drug prescribing before and during pregnancy in south west France: a retrolective study

S Crespin, R Bourrel, C Hurault-Delarue… - Drug safety, 2011 - Springer
Background: Several drugs that are known to exhibit teratogenic or fetotoxic risks when used
during pregnancy should not be prescribed to pregnant women. However, most women of …

Comparison of chronic analgesic drugs prevalence in Parkinson's disease, other chronic diseases and the general population

C Brefel-Courbon, S Grolleau, C Thalamas, R Bourrel… - PAIN®, 2009 - Elsevier
Patients with Parkinson’s disease (PD) frequently experienced pain. Nevertheless, there are
no epidemiological data about frequency of pain in PD. We compare pain prevalence using …

Predictors of cardiovascular hospitalization in giant cell arteritis: effect of statin exposure. A French population-based study

G Pugnet, L Sailler, JP Fournier, R Bourrel… - The Journal of …, 2016 - jrheum.org
Objective. To identify predictors and protectors for cardiovascular hospitalization in a giant
cell arteritis (GCA) population-based cohort. Methods. Using the French National Health …

Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study

G Pugnet, L Sailler, R Bourrel, JL Montastruc… - The Journal of …, 2015 - jrheum.org
Objective. To investigate the potential association between statin use and giant cell arteritis (GCA)
course. Methods. Using the French National Health Insurance system, we included …

[HTML][HTML] Drug–drug interactions with imatinib: an observational study

I Récoché, V Rousseau, R Bourrel, M Lapeyre-Mestre… - Medicine, 2016 - journals.lww.com
… Récoché, Isabelle PharmD a ; Rousseau, Vanessa PhD a ; Bourrel, Robert MD b ;
Lapeyre-Mestre, Maryse MD, PhD c ; Chebane, Leila MSc a ; Despas, Fabien PharmD, PhD …

Prescriptions et délivrances d'anti-inflammatoires non stéroïdiens après le 6e mois de grossesse: impact d'une lettre d'information envoyée par les autorités de santé

C Hurault, I Lacroix, R Bourrel, JL Montastruc… - La Presse Médicale, 2008 - Elsevier
Objective To evaluate the impact a year afterwards of a letter sent by French health authorities
(AFSSAPS) to health care professionals on 12 December 2003 to remind them that late …

[HTML][HTML] Clinical impact and cost-effectiveness of an education program for PD patients: a randomized controlled trial

…, L Pourcel, H Derumeaux, E Bérard, R Bourrel… - PLoS …, 2016 - journals.plos.org
Background Parkinson’s disease (PD) is characterized by its impact on quality of life,
constituting a substantial economic burden on society. Education programs implicating patients …

Coût de la polyarthrite rhumatoïde en France: comparaison léflunomide/étanercept

…, A Constantin, A Cambon-Thomsen, R Bourrel… - Therapie, 2007 - journal-therapie.org
Le traitement de la polyarthrite rhumatoïde (PR) a été profondément modifié avec l'apparition
en 1999 des anti-TNFα. Peut-on faire l'hypothèse que le coût de ces traitements innovants, …